|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-10-3
|
|
pubmed:abstractText |
Axillary lymph node status is the most important pathological determinant of prognosis in early breast cancer. However, axillary lymph node dissection (ALND) performed for pathological assessment is not without costs and morbidity. Recently, radioisotope-guided sentinel node biopsy (SNB) has been proposed as a promising technique for staging breast cancer patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
322-4
|
|
pubmed:dateRevised |
2008-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:11016716-Axilla,
pubmed-meshheading:11016716-Breast Neoplasms,
pubmed-meshheading:11016716-Clinical Competence,
pubmed-meshheading:11016716-Feasibility Studies,
pubmed-meshheading:11016716-Female,
pubmed-meshheading:11016716-Frozen Sections,
pubmed-meshheading:11016716-Gamma Rays,
pubmed-meshheading:11016716-Humans,
pubmed-meshheading:11016716-Italy,
pubmed-meshheading:11016716-Learning,
pubmed-meshheading:11016716-Lymph Nodes,
pubmed-meshheading:11016716-Lymphatic Metastasis,
pubmed-meshheading:11016716-Neoplasm Staging,
pubmed-meshheading:11016716-Practice Guidelines as Topic,
pubmed-meshheading:11016716-Radiopharmaceuticals,
pubmed-meshheading:11016716-Sensitivity and Specificity,
pubmed-meshheading:11016716-Sentinel Lymph Node Biopsy,
pubmed-meshheading:11016716-Technetium Tc 99m Aggregated Albumin
|
|
pubmed:articleTitle |
Lymphoscintigraphy and gamma probe tracing in detecting breast cancer lymph node involvement: can they replace axillary lymph node dissection?
|
|
pubmed:affiliation |
UO Medicina Nucleare Careggi, Azienda Ospedaliera Careggi, Florence, Italy. mednuc1@ao-careggi.toscana.it
|
|
pubmed:publicationType |
Journal Article
|
